|
Symbiotec Pharmalab Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
6928.42 Cr.
|
P/BV
|
6.02
|
Book Value (Rs.)
|
178.98
|
|
52 Week High/Low (Rs.)
|
1180/934
|
FV/ML
|
2/1
|
P/E(X)
|
63.05
|
|
Bookclosure
|
|
EPS (Rs.)
|
17.10
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 |
| No. of Equity Shares (in Lacs) | 627.35 | 546.82 | 546.82 |
| | | | |
| EQUITIES AND LIABILITIES | | | |
| SHAREHOLDER'S FUNDS | | | |
| Equity Share Capital | 12.55 | 10.94 | 10.94 |
| Total Share Capital | 12.55 | 10.94 | 10.94 |
| | | | |
| Reserves and Surplus | 1137.18 | 803.96 | 704.11 |
| Total Reserves and Surplus | 1137.18 | 803.96 | 704.11 |
| Total Shareholders Funds | 1149.73 | 814.89 | 715.05 |
| Minority Interest | -0.14 | -0.19 | -0.21 |
| | | | |
| NON-CURRENT LIABILITIES | | | |
| Long Term Borrowings | 68.41 | 253.01 | 195.24 |
| Deferred Tax Liabilities [Net] | 5.81 | 21.99 | 19.94 |
| Other Long Term Liabilities | 7.84 | 4.09 | 2.84 |
| Long Term Provisions | 21.57 | 13.25 | 10.70 |
| Total Non-Current Liabilities | 103.64 | 292.35 | 228.73 |
| | | | |
| CURRENT LIABILITIES | | | |
| Short Term Borrowings | 319.50 | 287.91 | 51.96 |
| Trade Payables | 138.33 | 88.50 | 227.61 |
| Other Current Liabilities | 63.15 | 92.07 | 68.00 |
| Short Term Provisions | 6.59 | 4.13 | 3.64 |
| Total Current Liabilities | 527.57 | 472.60 | 351.21 |
| | | | |
| Total Capital And Liabilities | 1780.79 | 1579.65 | 1294.79 |
| | | | |
| ASSETS | | | |
| NON-CURRENT ASSETS | | | |
| Tangible Assets | 1120.33 | 438.00 | 448.19 |
| Intangible Assets | 0.00 | 0.00 | 0.24 |
| Capital Work-In-Progress | 64.48 | 568.17 | 208.32 |
| Fixed Assets | 1184.81 | 1006.17 | 656.74 |
| Non-Current Investments | 4.48 | 1.45 | 3.51 |
| Other Non-Current Assets | 105.96 | 79.18 | 126.32 |
| Total Non-Current Assets | 1295.25 | 1086.79 | 786.58 |
| | | | |
| | | | |
| CURRENT ASSETS | | | |
| Inventories | 236.88 | 261.45 | 335.79 |
| Trade Receivables | 197.60 | 175.65 | 125.67 |
| Cash And Cash Equivalents | 10.13 | 26.47 | 7.56 |
| OtherCurrentAssets | 40.94 | 29.28 | 39.19 |
| Total Current Assets | 485.54 | 492.86 | 508.21 |
| | | | |
| Total Assets | 1780.79 | 1579.65 | 1294.79 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | |
| Contingent Liabilities | 100.37 | 37.22 | 122.70 |
| | | | |
| NON-CURRENT INVESTMENTS | | | |
| Non-Current Investments Unquoted Book Value | 4.48 | 1.45 | 3.51 |
